.

1. Volume 5 • Issue 3 • 1000205
J Bus Fin Aff
ISSN: 2167-0234 BSFA an open access journal
Research Article Open Access
Journal of
Business & Financial Affairs
JournalofBusiness & Fina
ncialAffairsISSN: 2167-0234
Luisetto, J Bus Fin Aff 2016, 5:3
DOI: 10.4172/2167-0234.1000205
*Corresponding author: Mauro Luisetto, Pharm D, Pharmacologist, European
Specialist in Laboratory Medicine, Hospital Pharmacist’s Manager, Italy, Tel:
+393402479620; E-mail: maurolu65@gmail.com
Received June 17, 2016; Accepted July 15, 2016; Published July 25, 2016
Citation: Luisetto M (2016) A New Management Healthcare Systems to Efficiently
Reduce Healthcare Costs: Clinical Pharmaceutical Care, Medical Laboratory
Imaging, Nuclear Medicine: A Synergy Instruments. J Bus Fin Aff 5: 205. doi:
10.4172/2167-0234.1000205
Copyright: © 2016 Luisetto M. This is an open-access article distributed under
the terms of the Creative Commons Attribution License, which permits unrestricted
use, distribution, and reproduction in any medium, provided the original author and
source are credited.
physicians, nurse, as a consultant in a homecare, out of the hospital
(Great opportunity when patients hospitalization is not necessary)
in the complex world of drugs therapies A consultant pharmacist
for patient can be a crucial point in the different medical healthcare
specialty [17,18].
Adding the clinical pharmacy skills and expertise in medicinal
chemistry and pharmacology to his/her clinical work, we can have an
improving the patients' clinical outcomes, and on patients quality of
life [19-22]. The hospital, institutions, the government or insurance
can receive a great benefit from this new working system (Economics
monitoring shows relevant reduction in therapy and diagnostic costs)
[23-25].
In ITALIAN Hospital MOLINETTE experience in 2007
“farmacista di reparto PROJECT “they have obtained reduction in
costs for drugs 41% (607.000,00 € less in ward) [26]. And reduction
possibility of pharmacological therapy errors Del 70% (prescriptions,
monitoring, subministration, dilution) (emergency surgery,
nephrology dialysis transplants, Oncohematology, urology UTI In the
Italian project FARMACISTA DI DIPARTIMENTO during 2010‐2011
(collaboration between FOFI, SIFO e il Ministero della Salute
organization) was obtained this results: reduction since 88% drugs
ward stokes and reducing 30% possibility of errors in drug therapy
adverse events, reducing healthcare costs and reducing recovering
days (oncohaematology), reducing drugs wards stores from dal 32%
and since fine all'88% (five hospital Torino, Padova, Ancona, Bari,
Taormina) Reduction costs about 35% obtained in this experience
and the significative reduction in possibility of errors represent a
fundamental baseline to start [27-32].
Keywords: Clinical pharmaceutical care; Clinical pharmacist;
Imaging; Medical laboratory; Hospital settings; Medication cost;
Clinical outcomes; Innovative therapy; Management, Budget analysis
Introduction
This statistic shows the U.S. national health expenditure, amounted
total health expenditure 3.0 billion U.S. dollars. The total nominal
spending on medicine in the United States 2010 in total medicine
expenditure in the United States was approximately 316 billion U.S.
dollars and in 2015 more than 400 clinical pharmaceutical care, MTM,
and consultant pharmacy service can be the right instruments in today
healthcare systems involved in the therapy decision making systems
[1-3]. In order to reduce costs the clinical pharmacist presence in
multidisciplinary medical team improves some clinical and economic
outcomes as demonstrated by many scientific articles (30% reducing
cost by drugs and medical devices). This is an opportunity public
authorities’, patients and insurance to contain costs (drugs, medical
devices, therapy errors and other) with the introduction of new and
innovative drugs, medical and new diagnostic procedures added to the
more complex pharmacological therapies and polytherapy there is a
great need of clinical pharmacist service [4,5].
Reduction of medication therapy errors is demanded by patients
and health authorities, government, insurances and other institutions.
Multiprofessional healthcare team is the right key way of work in today
health care systems [6].
A clinical pharmacist contributes in many scientific and healthcare
fields: hematology oncology, toxicology, nuclear medicine, infectious
diseases, emergency medicine, ICU, nephrology, nutrition service,
pain management and others. to create an efficient team, the clinical
pharmacists must improve their knowledge and skills, so they will be
prepared to use the data provided by imaging, medical laboratory,
biochemistry, microbiology toxicology, molecular biology, genetic and
immunohistochemistry labs [7-14].
The stabile presence of clinical pharmacists in medical equips
give a real difference in the management of new and innovative
pharmacological therapeutics, especially when there is to have heavy
cost containment [15,16].
This is not limited to hospitals settings but we think also in
community pharmacy; the clinical pharmacy can help patients,
A New Management Healthcare Systems to Efficiently Reduce
Healthcare Costs: Clinical Pharmaceutical Care, Medical Laboratory
Imaging, Nuclear Medicine: A Synergy Instruments
Luisetto M*
Pharm D, Pharmacologist, European Specialist in Laboratory Medicine, Hospital Pharmacist’s Manager, Italy
Abstract
ASHP Guidelines: Clinical pharmacy service, in which pharmacist provide direct patient care are important foundation
for successful medication utilization management program focused on managing drug cost. The purpose of this work is
to analyze the advantages played by ward clinical pharmacists as stabile members of medical equips with physicians,
other healthcare professionals and nurse. Using the data obtained by diagnostic activity (medicine laboratory and
imaging) to choose and monitor the therapy clinical pharmacist can reduce therapy costs in the same time improve
patients clinical outcomes, and increase of patients quality of life and safety. The application of management and ICT
principle can give significant reducing in healthcare process.

2. Citation: Luisetto M (2016) A New Management Healthcare Systems to Efficiently Reduce Healthcare Costs: Clinical Pharmaceutical Care, Medical
Laboratory Imaging, Nuclear Medicine: A Synergy Instruments. J Bus Fin Aff 5: 205. doi: 10.4172/2167-0234.1000205
Page 2 of 3
Volume 5 • Issue 3 • 1000205
J Bus Fin Aff
ISSN: 2167-0234 BSFA an open access journal
Materials and Methods
We observe and analyze some relevant biomedical woks involved
in the function of clinical pharmacist membership in the medical
equips and the results as follows:
Bond et al., in 2007clinical pharmacy service, pharmacy staffing,
and hospital mortality rates. “In seven hospitals, clinical pharmacy
service reduces mortality rates in a significant way [1,33].
Chisholm et al., 2010 in “Pharmacist's effect as team members
on patient care: systematic review and meta-analyses”: pharmacists
provided direct patient care has favorable effects across various patient
outcomes, health care settings, and disease states. (Significant p 0.005) [2].
2015 Pharmacist cognitive service and pharmaceutical care: today
and tomorrow outlook UKJPB M Luisetto et al., UK J Pharm and Biosci
3: 71. “The goal of this article is to improve the clinical pharmaceutical
care application in many countries with an advanced healthcare system
to provide more rational drug therapy or diagnostic systems to patients.
Whenitisnotpossible,itwouldbeagoodideausingpharmaceutical
carephilosophy,indefinitepopulationssuchas:severedisease,critically
ill, patients with multiple illnesses, transplants, immunosuppression,
oncology or other serious conditions, at least when the treatments cost
a lot. And in these studies, we observe a general positive influence of
pharmacist's presence in the medical team also in different clinical
outcomes [3].
Ward pharmacist economical assessment and actions: tools
and instruments, managements and Health economics principles,
pharmacoeconomy, healthcare management resource with rational
allocation cost analysis -cost- benefit, cost efficacy, cost effectiveness
(analytical way, cost center) budget control, budget impact
analysis, Appropriateness, Regulatory rules (central reimbursement
classification, limitation note etc.) formulary management, drug
restriction policy, Systematic approach or task force, team group,
project management, prioritizing activity, management strategies,
time management, drug budgeting (formulary/non formulary),
Cost containment targets defined, Medication cost management
project selection (ex. high expensive or high budget impact therapy),
Benchmarking, Data analysis, ICT management, Dose unit systems
(ex. to reduce waste), ICT, Computerized prescriptions systems,
Collaborative working group (team, central pharmacy, hospital
management) [31-33].
Ward clinical pharmacy service, clinical pharmacist with advanced
training dedicated to cost management project, Monitoring, Buying
strategy, Use of Evidence based criteria, biomedical literature use,
Generic drug intensive use, Drug day (ex to reduce waste), IV OS
switch (to reduce cost), IV waste reduction, Communication skills,
professional social media, Committee participation (departmental),
Updating.
Results
We observed in this bibliography an overall general positive effect
of the stabile presence of pharmacist in medical teams with significant
enhancement in different clinical or economic outcomes and reducing
healthcare costs.
Discussions
The observed results in this studies we think were due to medicine
laboratory and imaging knowledge and skills of the clinical pharmacist,
as stabile part of the equip in a hospital setting [4-8].
A rapid and efficient introduction of clinical pharmacist in medical
equip whit great economic results can be obtained using specific
psychological and behavior skills and Professional social media skills to
make link between researcher and the applied healthcare professional [9].
We have noticed that the diagnostic skills (imaging and medicine
laboratory) of the ward clinical pharmacist have resulted in a significant
impact on costs reducing, pharmacological therapy and its monitoring.
Conclusion
For cost reduction and patient safety the hospitals must engage and
ask an active role from clinical pharmacists, also in fields as medical
laboratory and imaging and other Discipline involved in therapy
management.
Isn't time for government, institutions health authorities,
university, hospitals, to deep use the skills and expertise of ward
clinical pharmacists to reduce the patients' life risks, improving clinical
outcomes with cost savings, when there is a high rise of the innovative
treatments costs?
We think that a management system involved in clinical
pharmacists with active participation in therapy Decision making
process will be the right keywords in today and future healthcare.
We submit to the scientific community and professionals “Clinical
Pharmaceutical Care” as new management discipline.
Discipline introduced to improve clinical and economic endpoint
in pharmacological therapy reducing therapy error with a more rational
application of human resource in medical team (clinical pharmacist).
This innovative approach takes advantages using the Management and
ICT principles.
We ask also to university and international organization involved
in hospitals accreditation and University to recognize this new health
care discipline in professional activity.
WethinkthatcoretrainingmustincludeprinciplesofManagement,
ICT, professional social media use behavior and psychological skills in
team working to be added to the classic clinical pharmacy curriculum
studiorum.
Philosophy theory but also practical applications (rotations and
management experience in field) we strongly ask to public or private
institution to apply this clinical pharmaceutical care a new management
discipline to obtain more rational drug therapies and the right way to
use the clinical pharmacist human resource time.
Conflict of Interests
There is no conflict of interests from authors.
References
1. Bond CA, Raehl CL (2007) Clinical pharmacy service, pharmacy staffing and
hospital mortality rates. Pharmacotherapy 27: 481-493.
2. Chisholm BMA, Kim Lee J, Spivey CA, Slack M, Herrier RN, et al. (2010) US
pharmacist’s effect as team members on patient care: Systematic review and
meta-analyses. Med Care 48: 923-933.
3. Luisetto M, Francesca C, Giovanni B, Behzad NA (2015) Pharmacist Cognitive
Service and Pharmaceutical Care Today and Tomorrow Outlook. UKSPB 3:
67-72.
4. Stanley MS (1994) Diagnostic Imaging and Pharmaceutical Care. American
Journal of Pharmaceutical Education 58: 2.
5. Howard P (1984) An introduction to the Clinical Laboratory for Pharmacists.
Hosp Pharm 19: 425-431.

3. Citation: Luisetto M (2016) A New Management Healthcare Systems to Efficiently Reduce Healthcare Costs: Clinical Pharmaceutical Care, Medical
Laboratory Imaging, Nuclear Medicine: A Synergy Instruments. J Bus Fin Aff 5: 205. doi: 10.4172/2167-0234.1000205
Page 3 of 3
Volume 5 • Issue 3 • 1000205
J Bus Fin Aff
ISSN: 2167-0234 BSFA an open access journal
6. Luisetto M, Sahu RK (2016) Clinical Pharmaceutical Care: A New Management
Health Care Discipline. UKJPB 6:573.
7. Luisetto M, Cabianca L (2016) Psychological and Behavior Skills for Ph. Care
Practice in Medical Team 2016. IJPPR 5: 1-4.
8. Luisetto M, Nili-Ahmadabadi B, Cabianca L, Mokbul MI (2016) Steps and
Impacts of Pharmaceutical Care and Clinical Pharmacy Development on
Clinical Outcomes 2016: A Historical Analysis Compared with Results.
Clinician’s teamwork bulletin 1: 4-8.
9. Luisetto M, Mokbul MI, Luca C (2016) Professional Social Media: Instrument to
Meet Researcher and Healthcare Instruments with a Model for a New Scientific
Social Network. International Journal of Economics and Management Science
5: 1-2.
10. Luisetto M (2016) Clinical Pharmaceutical Care, Medical Laboratory Imaging,
Nuclear Medicine: A Synergy to Improve Clinical Outcomes and Reducing
Costs. J App Pharm 8: e112.
11. Tunnecliff J, Ilic D, Morgan P, Keating J, Gaida JE, et al. (2015) The acceptability
among health researchers and clinicians of social media to translate research
evidence to clinical practice: mixed-methods survey and interview study. J Med
Internet Res 17: e119.
12. Mekaru SR, Brownstein JS (2014) One Health in social networks and social
media. Rev Sci Tech 33: 629-637.
13. Thompson MA, Majhail NS, Wood WA, Perales MA (2015) Social Media and
the Practicing Hematologist: Twitter 101 for the Busy Healthcare Provider. Curr
Hematol Malig Rep 10: 405-412.
14. Kind T, Evans Y (2015) Social media for lifelong learning. Int Rev Psychiatry
27: 124-132.
15. Rodríguez SME, Gómez-RJ, Álvarez MM, Tortolero L, Ribal MJ, et al. (2016)
Spanish adaptation of the recommendations for the appropriate use of social
networks in urology of the European Association of Urology. Actas Urol Esp.
16. Panahi S, Watson J, Partridge H (2016) Fostering interpersonal trust on social
media: Physicians' perspectives and experiences. Postgrad Med J 92: 70-73.
17. Jackson J, Kennedy M (2015) Developing a social media platform for nurses.
Nurs Stand 30: 45-52.
18. Ranschaert ER, Van Ooijen PM, Lee S, Ratib O, Parizel PM (2015) Social
media for radiologists: An introduction. Insights Imaging 6: 741-752.
19. Denecke K, Bamidis P, Bond C, Gabarron E, Househ M, et al. (2015) Ethical
Issues of Social Media Usage in Healthcare. Yearb Med Inform 10: 137-147.
20. Chan C (2015) A Scoping Review of Social Media Use in Social Work Practice.
J Evid Inf Soc Work 13: 263-276.
21. Steele SR, Arshad S, Bush R, Dasani S, Cologne K, et al. (2015) Social media
is a necessary component of surgery practice. Surgery 158: 857-862.
22. Kitching F, Winbolt M, MacPhail A, Ibrahim JE (2015) Web-based social media
for professional medical education: Perspectives of senior stakeholders in the
nursing home sector. Nurse Educ Today 35: 1192-1198.
23. Papadopoulos (2002) The critical care pharmacist: An essential intensive care
practitioner. Pharmacotherapy 22: 1484-1488.
24. Koshman SL, Charrios TL, Simpson SH, McAlister FA, Tsuyuki RT (2008)
Pharmacist Care of Patient with Heart Failure: A Systematic Review of
Randomized Trials. Arch Intern Med 168: 687-694.
25. Luisetto M, Almadabadi BN (2016) An Open Letter to All Clinical Pharmacists:
2016 Pharmaceutical Care, Medical Laboratory, Nuclear Medicine and Imaging.
Clinicians Teamwork Bulletin 1: 1-3.
26. Hepler CD, Strand LM (1989) Opportunities and responsibilities in
pharmaceutical care. Am J Hosp Pharm 47: 533-543.
27. Suseno M, Tedeski L, Kent S, Rough S (1998) Impact of documented
pharmacists intervention on patient care and costs. Hosp. Pharm 33: 676-681
28. Papadopoulos J, Rebuck JA, Lober C, Pass SE, Seidl EC, et al. (2002)
The critical care pharmacist: An essential intensive care practitioner.
Pharmacotherapy 22: 1484-1488.
29. Bond CA, Raehl CL (2007) Clinical and economic outcomes of pharmacist-
managed antimicrobial prophylaxis in surgical patients. Am J Health Syst
Pharm 64: 1935-1942.
30. Kaboli PJ, Hoth AB, McClimon BJ, Schnipper JL (2006) Clinical pharmacists
and inpatient medical care: A systematic review. Archives of Internal Medicine
166: 955-964.
31. De Rijid T, Willems L, Simoens S (2008) Economic effects of clinical pharmacy
interventions: A literature review. Am j. health syst Pharm 65: 1161-1672.
32. Nkansah N, Mostovetsky O, Yu C, Chheng T, Beney J, et al. (2010) Effect
of outpatient pharmacist's non-dispensing role on patient outcomes and
prescribing patterns. Cochrane database of systematic reviews 7: CD000336.
33. ACCP (2014) Standards of practice for clinical pharmacists. Pharmacotherapy
34: 1-4.
Citation: Luisetto M (2016) A New Management Healthcare Systems to
Efficiently Reduce Healthcare Costs: Clinical Pharmaceutical Care, Medical
Laboratory Imaging, Nuclear Medicine: A Synergy Instruments. J Bus Fin Aff 5:
205. doi: 10.4172/2167-0234.1000205
OMICS International: Publication Benefits & Features
Unique features:
• Increased global visibility of articles through worldwide distribution and indexing
• Showcasing recent research output in a timely and updated manner
• Special issues on the current trends of scientific research
Special features:
• 700+ Open Access Journals
• 50,000+ editorial team
• Rapid review process
• Quality and quick editorial, review and publication processing
• Indexing at major indexing services
• Sharing Option: Social Networking Enabled
• Authors, Reviewers and Editors rewarded with online Scientific Credits
• Better discount for your subsequent articles
Submit your manuscript at: http://www.omicsonline.org/submission